{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:28:04Z","timestamp":1794302884930,"version":"4.9.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajo.2026.08.009","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:02:31Z","timestamp":1786946551000},"page":"345-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LXXXIII Jackson Memorial Lecture: Predicting the Future of Uveitis"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6395-5881","authenticated-orcid":false,"given":"Janet L.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0001","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/archophthalmol.2011.353","article-title":"The influence of Derrick T. Vail Sr, MD, and Edward M. Jackson, MD, on the creation of the American Board of Ophthalmology and the Specialist Board System in the United States","volume":"130","author":"O'Day","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(14)72105-1","article-title":"Edward Jackson in 1896: a man and his specialty at a crossroads. LIII Edward Jackson Memorial Lecture: part 1","volume":"122","author":"Albert","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0003","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0161-6420(88)33158-1","article-title":"Edward Jackson, MD\u2013a historical perspective of his contributions to refraction and to ophthalmology","volume":"95","author":"Newell","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.08.009_bib0004","unstructured":"Parsons JH. Diseases of the Eye. 6th ed. London: J & A Churchill; 1931:644."},{"issue":"12","key":"10.1016\/j.ajo.2026.08.009_bib0005","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jamaophthalmol.2013.917","article-title":"Evolution and impact of eye and vision terms in written English","volume":"131","author":"Leffler","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"23","key":"10.1016\/j.ajo.2026.08.009_bib0006","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.2025.1597","article-title":"Cataracts: a review","volume":"333","author":"Chen","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0007","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.2020.20245","article-title":"Refractive surgery in the US in 2021","volume":"326","author":"Jabbour","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2026.08.009_bib0008","doi-asserted-by":"crossref","DOI":"10.2147\/OPTH.S576219","article-title":"Influence of refractive error, age, and ophthalmic anatomical characteristics on refractive surgery choices","volume":"20","author":"Wortz","year":"2026","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0009","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ophtha.2015.11.001","article-title":"Rates of vitrectomy among enrollees in a United States Managed Care Network, 2001-2012","volume":"123","author":"Wubben","year":"2016","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.009_bib0010","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00417-013-2464-7","article-title":"Global rates of glaucoma surgery","volume":"251","author":"Mansouri","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.009_bib0011","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/ICO.0000000000003180","article-title":"Keratoplasty in the United States: trends and indications from 2015 to 2020","volume":"42","author":"Xiao","year":"2023","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.009_bib0012","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.ophtha.2018.04.024","article-title":"Strabismus, strabismus surgery, and reoperation rate in the United States: analysis from the IRIS registry","volume":"125","author":"Repka","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaapos.2026.104750","article-title":"The history and evolution of pediatric ophthalmology training: celebrating 50 years of the American Association for Pediatric Ophthalmology and Strabismus","volume":"30","author":"Donahue","year":"2026","journal-title":"J AAPOS"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.009_bib0014","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archopht.116.7.917","article-title":"Subspecialty distributions of ophthalmologists in the workforce","volume":"116","author":"Lee","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1186\/s12913-019-4590-3","article-title":"Research productivity across different ophthalmic subspecialties in the United States","volume":"19","author":"Gershoni","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0016","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ophtha.2011.11.017","article-title":"Uveitis is a subspeciality","volume":"119","author":"Smith","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.009_bib0017","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ophtha.2010.10.023","article-title":"Subspecialization of the ophthalmic literature: a review of the publishing trends of the top general, clinical ophthalmic journals","volume":"118","author":"Kumar","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12348-025-00490-w","article-title":"Uveitis output in high-impact clinical ophthalmology journals: a bibliometric analysis","volume":"15","author":"Nguyen","year":"2025","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100395","article-title":"Evaluation of publications from the American Academy of Ophthalmology: a 5-year analysis of ophthalmology literature","volume":"3","author":"Kalaw","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ajo.2026.08.009_bib0020","unstructured":"Ford J. Uveitis corner: spotlight on young uveitis specialists. Retinal Phys. 2024;21:18\u201319."},{"key":"10.1016\/j.ajo.2026.08.009_bib0021","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajo.2026.03.021","article-title":"Forecasting the workforce of uveitis specialists","volume":"287","author":"Shah","year":"2026","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0022","article-title":"Characteristics of uveitis specialists and disparities in geographic access to uveitis care in the United States","author":"Gopal","year":"2025","journal-title":"J Vitreoretin Dis"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0023","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.survophthal.2012.04.001","article-title":"Whatever happened to the EENT specialists?","volume":"58","author":"Truhlsen","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0024","doi-asserted-by":"crossref","first-page":"m4979","DOI":"10.1136\/bmj.m4979","article-title":"Uveitis for the non-ophthalmologist","volume":"372","author":"Burkholder","year":"2021","journal-title":"BMJ."},{"issue":"5","key":"10.1016\/j.ajo.2026.08.009_bib0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jama.2025.4358","article-title":"Uveitis in adults: a review","volume":"334","author":"Maghsoudlou","year":"2025","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0026","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.survophthal.2023.02.007","article-title":"Artificial intelligence in uveitis: a comprehensive review","volume":"68","author":"Nakayama","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0027","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.2147\/OPTH.S495307","article-title":"Artificial intelligence in uveitis: innovations in diagnosis and therapeutic strategies","volume":"18","author":"Murugan","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0028","unstructured":"McLeod SD. EyeNet Magazine. The MD and AI: harnessing new tools for our patients. American Academy of Ophthalmology; 2026."},{"key":"10.1016\/j.ajo.2026.08.009_bib0029","series-title":"Understanding Viewpoints: Evaluation of Applications and Applicants (UVEA) Task Force","author":"Gonzales","year":"2026"},{"key":"10.1016\/j.ajo.2026.08.009_bib0030","article-title":"Understanding perceptions of ophthalmology residents on pursuing a uveitis fellowship","volume":"6","author":"Bosque","year":"2026","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"10.1016\/j.ajo.2026.08.009_bib0031","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ajo.2025.06.042","article-title":"Burnout among united states uveitis specialists-an assessment of prevalence and contributing factors","volume":"279","author":"Thomas","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0032","article-title":"Current landscape of uveitis specialists in the United States","volume":"14","author":"Tsui","year":"2022","journal-title":"J Acad Ophthalmol (2017)"},{"key":"10.1016\/j.ajo.2026.08.009_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2026.0901","article-title":"Financial return on investment of fellowship training in ophthalmology","author":"Azzam","year":"2026","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0034","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajo.2021.06.011","article-title":"Factors influencing career decisions and satisfaction among newly practicing ophthalmologists","volume":"234","author":"Gedde","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.009_bib0035","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaophthalmol.2016.3229","article-title":"Prevalence of noninfectious uveitis in the United States: a claims-based analysis","volume":"134","author":"Thorne","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0036","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajo.2025.03.032","article-title":"Incidence and prevalence of uveitis and associated ocular complications in the United States TriNetX database","volume":"276","author":"Kirupaharan","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.009_bib0037","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/09286586.2021.1882506","article-title":"Prevalence and incidence of uveitis: a systematic review and meta-analysis","volume":"28","author":"Garc\u00eda-Aparicio","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30488-5","article-title":"The Lancet Global Health Commission on Global Eye Health: vision beyond 2020","volume":"9","author":"Burton","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0039","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ophtha.2015.10.028","article-title":"Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis","volume":"123","author":"Dick","year":"2016","journal-title":"Ophthalmology"},{"issue":"19","key":"10.1016\/j.ajo.2026.08.009_bib0040","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2017.5103","article-title":"Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitis","volume":"317","author":"Kempen","year":"2017","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ajo.2026.08.009_bib0041","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1038\/s41433-024-03238-3","article-title":"Characterization and prevalence of ocular comorbidities and risk of legal blindness across the United States","volume":"38","author":"Chu","year":"2024","journal-title":"Eye (Lond)"},{"issue":"12","key":"10.1016\/j.ajo.2026.08.009_bib0042","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1007\/s00417-025-06947-x","article-title":"Visual acuity and ocular comorbidities in patients aged 100 years and older: a retrospective, crosssectional study","volume":"263","author":"Ono","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.08.009_bib0043","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41433-026-04335-1","article-title":"Pigment loss and pseudo-albinism in Birdshot chorioretinitis","volume":"40","author":"Vienne-Jumeau","year":"2026","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2026.08.009_bib0044","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajo.2026.01.020","article-title":"Risk of glaucoma in patients with idiopathic noninfectious uveitis: a multi-institutional real-world retrospective cohort study","volume":"285","author":"Liu","year":"2026","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.009_bib0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ophtha.2020.08.035","article-title":"Seven-year outcomes of uveitic macular edema: the multicenter uveitis steroid treatment trial and follow-up study results","volume":"128","author":"Tomkins-Netzer","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.08.009_bib0046","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ajo.2023.06.023","article-title":"Cataract surgery in patients with uveitis treated with systemic therapy in the multicenter uveitis steroid treatment (MUST) trial and follow-up study: risk factors and outcomes","volume":"254","author":"Jabs","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0047","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40123-020-00245-x","article-title":"A cross-sectional online survey identifies subspecialty differences in the management of pediatric cataracts associated with uveitis","volume":"9","author":"Carpentier","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ajo.2026.08.009_bib0048","first-page":"1","article-title":"Impact of socioeconomic disadvantage on clinical outcomes of inflammatory eye disease patients requiring systemic immunosuppression","author":"Trudrung","year":"2026","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.009_bib0049","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/bjophthalmol-2018-312048","article-title":"Uveitis and health disparities: results from the national inpatient sample","volume":"103","author":"Chauhan","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.009_bib0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ophtha.2025.01.012","article-title":"Barriers to health care access and use among racial and ethnic minorities with noninfectious uveitis","volume":"132","author":"Montazeri","year":"2025","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0051","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-026-03758-1","article-title":"Novel advances in juvenile idiopathic arthritis associated uveitis","volume":"28","author":"Patel","year":"2026","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajo.2026.08.009_bib0052","first-page":"1","article-title":"Incidence and prevalence of depression, anxiety, and suicidal ideation in patients with uveitis and scleritis in the TriNetX database","author":"Agarwal","year":"2026","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"10.1016\/j.ajo.2026.08.009_bib0053","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/acr.23224","article-title":"Impact of uveitis on quality of life in adult patients with juvenile idiopathic arthritis","volume":"69","author":"Haasnoot","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.009_bib0054","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/09286586.2020.1856385","article-title":"The impact of adult uveitis on quality of life: an exploratory study","volume":"28","author":"Prem Senthil","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2024.10.027","article-title":"Humanistic burden of noninfectious uveitis: a systematic review and meta-analysis","volume":"271","author":"Sriranganathan","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0056","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamaophthalmol.2018.5893","article-title":"Association between noninfectious uveitis and psychological stress","volume":"137","author":"Berlinberg","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0057","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ajo.2011.06.028","article-title":"Depression and visual functioning in patients with ocular inflammatory disease","volume":"153","author":"Qian","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.08.009_bib0058","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.18240\/ijo.2022.08.23","article-title":"Risk of anxiety and depression in patients with uveitis: a meta-analysis","volume":"15","author":"Cui","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0059","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2026.08.009_bib0060","article-title":"Genomic network analysis links uveitis with systemic inflammatory diseases","author":"Chau","year":"2026","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0061","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41435-022-00168-6","article-title":"Progress in the genetics of uveitis","volume":"23","author":"Huang","year":"2022","journal-title":"Genes Immun"},{"key":"10.1016\/j.ajo.2026.08.009_bib0062","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2026.01.004","article-title":"Exploring the association between autoimmune and inflammatory diseases and uveitis","volume":"284","author":"Mohan","year":"2026","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.009_bib0063","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.13049","article-title":"Immune-mediated inflammatory diseases following pediatric uveitis diagnosis","volume":"9","author":"Kwak","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0064","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","article-title":"International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease","volume":"103","author":"Bloch-Michel","year":"1987","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0066","doi-asserted-by":"crossref","DOI":"10.1111\/ceo.14175","article-title":"The standardisation of uveitis nomenclature (SUN) project","author":"Jabs","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0067","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.ajo.2021.05.006","article-title":"Here Comes the SUN (Part 2): standardization of uveitis nomenclature for disease classification criteria","volume":"228","author":"Van Gelder","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0068","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ajo.2022.04.007","article-title":"Evaluation of the SUN classification criteria for uveitides in an academic uveitis practice","volume":"241","author":"Mudie","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0069","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajo.2017.10.028","article-title":"Interobserver agreement among uveitis experts on uveitic diagnoses: the standardization of uveitis nomenclature experience","volume":"186","author":"Jabs","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ajo.2025.06.033","article-title":"Evidence and consensus-based imaging guidelines in noninfectious posterior uveitis-methodology of the multimodal imaging in uveitis (MUV) project report 2","volume":"278","author":"Gupta","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2025.07.002","article-title":"Systematic review of clinical utility of multimodal imaging in non-infectious posterior uveitis: MUV project report 3","author":"Accorinti","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2025.05.052","article-title":"Evidence and consensus based guidelines for imaging in serpiginous choroiditis - multimodal imaging in uveitis (MUV) taskforce: report 4: imaging guidelines for serpiginous choroiditis","author":"Agarwal","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0073","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajo.2025.04.018","article-title":"Evidence and consensus-based imaging guidelines in multifocal choroiditis with panuveitis and punctate inner choroiditis-multimodal imaging in uveitis (MUV) taskforce report 5","volume":"276","author":"Gangaputra","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0074","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ajo.2025.06.039","article-title":"Evidence and consensus based imaging guidelines in multiple evanescent white dot syndrome multimodal imaging in uveitis (MUV) taskforce report 6","volume":"278","author":"Munk","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajo.2025.06.007","article-title":"Evidence and consensus-based imaging guidelines in acute posterior multifocal placoid pigment epitheliopathy (APMPPE) - multimodal imaging in uveitis (MUV) taskforce report 7","volume":"278","author":"Carre\u00f1o","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0076","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ajo.2025.06.029","article-title":"Evidence and consensus-based imaging guidelines in birdshot chorioretinopathy: multimodal imaging in uveitis (MUV) taskforce report 8","volume":"278","author":"Pichi","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2026.05.004","article-title":"Evidence and consensus-based imaging guidelines in cytomegalovirus retinitis: multimodal imaging in uveitis (MUV) task force - report 15","author":"Leal","year":"2026","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajo.2026.08.009_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2026.05.011","article-title":"Evidence and consensus-based guidelines in Vogt-Koyanagi-Harada disease. Multimodal imaging in uveitis (MUV) taskforce report 16","author":"Yang","year":"2026","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajo.2026.08.009_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2026.06.023","article-title":"Evidence and consensus based guidelines for imaging in tubercular choroiditis. multimodal imaging in uveitis (MUV) taskforce: report 17","author":"Janetos","year":"2026","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2026.08.009_bib0080","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","article-title":"Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1","volume":"135","author":"Agrawal","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0081","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/09273948.2017.1406529","article-title":"The Collaborative Ocular Tuberculosis Study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends","volume":"27","author":"Agarwal","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.ajo.2026.08.009_bib0082","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/09273948.2020.1761400","article-title":"The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 165 patients with tubercular anterior uveitis","volume":"28","author":"Agrawal","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.ajo.2026.08.009_bib0083","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09273948.2020.1808226","article-title":"The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 447 patients with tubercular intermediate uveitis and panuveitis","volume":"28","author":"Agrawal","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.ajo.2026.08.009_bib0084","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09273948.2018.1489061","article-title":"The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis","volume":"28","author":"Agrawal","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.ajo.2026.08.009_bib0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09273948.2020.1774905","article-title":"Visual morbidity in ocular tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: report #6","volume":"28","author":"Agrawal","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.ajo.2026.08.009_bib0086","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/09273948.2020.1761401","article-title":"Twenty-four month outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: defining the \"Cure\" in ocular tuberculosis","volume":"28","author":"Agarwal","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.ajo.2026.08.009_bib0087","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09273948.2019.1653933","article-title":"Standardization of nomenclature for ocular tuberculosis - results of Collaborative Ocular Tuberculosis Study (COTS) workshop","volume":"28","author":"Agrawal","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0088","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ophtha.2020.01.008","article-title":"Collaborative Ocular Tuberculosis Study Consensus Guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0089","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ophtha.2020.06.052","article-title":"Collaborative Ocular Tuberculosis Study Consensus Guidelines on the management of tubercular uveitis-report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"issue":"sup1","key":"10.1016\/j.ajo.2026.08.009_bib0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/09273948.2019.1646774","article-title":"Tubercular uveitis: nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1","volume":"28","author":"Testi","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0091","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.survophthal.2025.01.012","article-title":"Global demographic and etiological variations of retinal vasculitis: a systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) report 1","volume":"70","author":"Cifuentes-Gonz\u00e1lez","year":"2025","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0092","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.survophthal.2025.09.011","article-title":"Work-up in patients with retinal vasculitis: a systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) report 2","volume":"71","author":"Cifuentes-Gonz\u00e1lez","year":"2026","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.009_bib0093","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.survophthal.2025.04.001","article-title":"Clinical features of retinal vasculitis: a systematic review and meta-analysis from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) report 3","volume":"70","author":"Cifuentes-Gonz\u00e1lez","year":"2025","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0094","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.survophthal.2025.09.013","article-title":"Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: a systematic review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) - report 4","volume":"71","author":"Saboya-Galindo","year":"2026","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0095","first-page":"1","article-title":"A survey of diagnostic and management practices in retinal vasculitis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe)-report 5","author":"Liu","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.009_bib0096","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1080\/09273948.2025.2566981","article-title":"Complexities in the terminology used for describing, diagnosing, and classifying retinal vasculitis: a scoping review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe)-report 6","volume":"33","author":"Chua","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0097","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40123-023-00863-1","article-title":"Effectiveness and safety of biosimilars in pediatric non-infectious uveitis: real-life data from the International AIDA Network Uveitis Registry","volume":"13","author":"Tarsia","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0098","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/09273948.2024.2346815","article-title":"Impact of HLA-B51 on uveitis and retinal vasculitis: data from the AIDA International Network Registries on ocular inflammatory disorders","volume":"33","author":"Sota","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.009_bib0099","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/ceo.14534","article-title":"Adalimumab monotherapy or combination therapy with methotrexate in paediatric uveitis: data from the AIDA Network Uveitis Registry","volume":"53","author":"Gaggiano","year":"2025","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.009_bib0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bjo-2025-327410","article-title":"Tocilizumab effectiveness in paediatric non-infectious uveitis: data from the International AIDA Network Registries on ocular inflammatory disorders","volume":"109","author":"Sota","year":"2025","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.009_bib0101","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s40123-025-01237-5","article-title":"Incidence and predictors of ocular complications in pediatric-onset uveitis: data from the AIDA Network Uveitis Registry","volume":"14","author":"Gaggiano","year":"2025","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ajo.2026.08.009_bib0102","article-title":"Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the International AIDA Network Uveitis Registry","volume":"12","author":"Sota","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0103","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40123-025-01258-0","article-title":"The risk of developing ocular involvement among Beh\u00e7et's disease patients presenting with mucocutaneous involvement at disease onset: data from the International AIDA Network Beh\u00e7et's Disease Registry","volume":"15","author":"Vitale","year":"2026","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ajo.2026.08.009_bib0104","doi-asserted-by":"crossref","DOI":"10.1007\/s40123-026-01390-5","article-title":"Determinants of non-infectious scleritis complications and their impact on visual outcome: results from the International AIDA Network Scleritis Registry","author":"Sota","year":"2026","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41433-023-02630-9","article-title":"The infectious uveitis treatment algorithm network (TITAN) report 1-global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster virus anterior uveitis","volume":"38","author":"Thng","year":"2024","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0106","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41433-023-02631-8","article-title":"The Infectious Uveitis Treatment Algorithm Network (TITAN) report 2-global current practice patterns for the management of cytomegalovirus anterior uveitis","volume":"38","author":"Thng","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2026.08.009_bib0107","author":"Putera","year":"2025","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.ajo.2026.08.009_bib0108","unstructured":"Acharya N. From Clinic to Evidence: Advancing Resarch in Ocular Infection and Inflammation. Mildred Weisenfeld Award Lecture: Association of Research in Vision and Ophthalmology (ARVO) Annual Meeting, Denver Colorado USA. May 6, 2026. https:\/\/www.youtube.com\/watch?v=vkiF-wyI66I. Accessed September 6, 2026, 10:40 AM."},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0109","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ophtha.2025.10.004","article-title":"Adalimumab versus conventional immunosuppression for uveitis (ADVISE) trial","volume":"133","author":"Jabs","year":"2026","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bjo-2024-326239","article-title":"Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice","volume":"109","author":"Branford","year":"2025","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101380","article-title":"Immunomodulatory therapy in non-infectious uveitis: current landscape, gaps, and future directions","volume":"108","author":"Agrawal","year":"2025","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2026.08.009_bib0112","doi-asserted-by":"crossref","first-page":"14441","DOI":"10.2147\/JIR.S540821","article-title":"Safe use of corticosteroids in non-infectious uveitis","volume":"18","author":"Belletti","year":"2025","journal-title":"J Inflamm Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0113","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12969-024-01022-x","article-title":"Implementation study of the CARRA uveitis consensus treatment plans: feasibility for clinical practice and applicability for research","volume":"22","author":"Chang","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2015.07.001","article-title":"The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management","volume":"61","author":"Foster","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.009_bib0115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","article-title":"Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitiS (FOCUS) initiative","volume":"125","author":"Dick","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.08.009_bib0116","article-title":"The immunopathogenesis of uveitis","volume":"13","author":"Han","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajo.2026.08.009_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108618","article-title":"The role of the inflammasomes in the pathogenesis of uveitis","volume":"208","author":"Xu","year":"2021","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0118","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2025-002456","article-title":"Drug-induced immune-mediated uveitis: a real-world pharmacovigilance analysis using FAERS and JADER databases","volume":"10","author":"Xu","year":"2025","journal-title":"BMJ Open Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0119","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s12026-015-8762-x","article-title":"Association of the C2-CFB locus with non-infectious uveitis, specifically predisposed to Vogt-Koyanagi-Harada disease","volume":"64","author":"Yang","year":"2016","journal-title":"Immunol Res"},{"key":"10.1016\/j.ajo.2026.08.009_bib0120","unstructured":"Yang MM, Lai TY, Tam PO, et al. Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis. Mol Vis. 2012;18:1865\u201372."},{"key":"10.1016\/j.ajo.2026.08.009_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101354","article-title":"Gene therapy-associated uveitis (GTAU): understanding and mitigating the adverse immune response in retinal gene therapy","volume":"106","author":"Purdy","year":"2025","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0122","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41564-026-02266-x","article-title":"An emerging human eye disease is associated with aquatic virus zoonotic infection","volume":"11","author":"Liu","year":"2026","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0123","doi-asserted-by":"crossref","DOI":"10.1007\/s00011-026-02350-2","article-title":"Immunometabolic regulation and tissue-resident immunity in autoimmune uveitis: from genetic susceptibility to the gut-spleen-eye axis","volume":"75","author":"Lin","year":"2026","journal-title":"Inflamm Res"},{"key":"10.1016\/j.ajo.2026.08.009_bib0124","article-title":"Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries","volume":"11","author":"Vitale","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.009_bib0125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaophthalmol.2024.2439","article-title":"Filgotinib in active noninfectious uveitis: the HUMBOLDT randomized clinical trial","volume":"142","author":"Srivastava","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.009_bib0126","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4103\/IJO.IJO_61_25","article-title":"JAK-STAT inhibitors in noninfectious uveitis - a review","volume":"73","author":"Pyare","year":"2025","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0127","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41433-025-04065-w","article-title":"The use of Janus kinase inhibitors to treat noninfectious uveitis","volume":"40","author":"Beckman","year":"2026","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ophtha.2025.10.010","article-title":"VVN461 solution in patients with acute noninfectious anterior uveitis","volume":"133","author":"Yang","year":"2026","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2026.08.009_bib0129","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104515","article-title":"Evolving landscape of small-molecule immunotherapeutics for uveitis: a scoping review","volume":"30","author":"Yim","year":"2025","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ajo.2026.08.009_bib0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajo.2025.12.034","article-title":"Dazdotuftide: novel treatment for noninfectious uveitis with superior intraocular pressure safety profile: a randomized clinical trial","volume":"284","author":"Chu","year":"2026","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0131","series-title":"Our Pipeline","year":"2026"},{"key":"10.1016\/j.ajo.2026.08.009_bib0132","unstructured":"Sharma S. Bispecific trap-antibody inhibiting interleukin-6 and vascular endothelial growth factor (KSI-101): Phase 1b APEX Study in patients with macular edema secondary to inflammation (MESI). Power point presentation presented at: Angiogenesis 2026; February 7, 2026 2026; Virtual. https\/\/umiamihealth.org\/en\/bascom-palmerl-eye-institute\/halthcare-professionals\/continuing-medical-education\/angiogenesis\/program. Accessed September 6, 2026."},{"issue":"5","key":"10.1016\/j.ajo.2026.08.009_bib0133","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamaophthalmol.2026.0610","article-title":"Interleukin 6 inhibition with Vamikibart for uveitic macular edema: the phase 1 DOVETAIL nonrandomized clinical trial","volume":"144","author":"Sharma","year":"2026","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0134","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110456","article-title":"Breaking barriers in ocular drug delivery for uveitis: advanced drug delivery systems, challenges and future prospects","volume":"257","author":"Ambekar","year":"2025","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2026.08.009_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118911","article-title":"Revolutionizing uveitis treatment with nanotechnology: innovations, barriers, and strategic solutions","volume":"194","author":"Johari","year":"2026","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajo.2026.08.009_bib0136","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.2147\/IJN.S532074","article-title":"Nanomedicine-based ophthalmic drug delivery systems for the treatment of ocular diseases","volume":"20","author":"Lin","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ajo.2026.08.009_bib0137","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2026.111041","article-title":"In vivo engineering of immunosuppressive T cells to treat ocular autoimmune diseases","volume":"268","author":"Wang","year":"2026","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2026.08.009_bib0138","article-title":"CAR-Treg cell therapies and their future potential in treating ocular autoimmune conditions","volume":"3","author":"Abraham","year":"2023","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"10.1016\/j.ajo.2026.08.009_bib0139","article-title":"Next-generation sequencing and immuno-informatics for designing a multi-epitope vaccine against HSV-1-induced uveitis","volume":"16","author":"Cao","year":"2025","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0140","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14030286","article-title":"Human retinal organoid model of ocular toxoplasmosis","volume":"14","author":"Ashander","year":"2025","journal-title":"Pathogens."},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0141","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.survophthal.2023.01.006","article-title":"Stepwise approach for fundus imaging in the diagnosis and management of posterior uveitis","volume":"68","author":"Agarwal","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0142","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2026.03.011","article-title":"Imaging measures for the assessment of disease activity in noninfectious posterior uveitis - multimodal imaging in uveitis (MUV) taskforce: report 10","volume":"287","author":"Agarwal","year":"2026","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.110327","article-title":"Automatic transformer-based grading of multiple retinal inflammatory signs in uveitis on fluorescein angiography","volume":"193","author":"Amiot","year":"2025","journal-title":"Comput Biol Med"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.009_bib0144","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41433-025-03697-2","article-title":"Differentiation of anterior chamber pigment and inflammatory cells using swept-source optical coherence tomography: a cross-sectional study","volume":"39","author":"Bellchambers","year":"2025","journal-title":"Eye (Lond)"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.009_bib0145","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.ophtha.2017.05.013","article-title":"Objective quantification of anterior chamber inflammation: measuring cells and flare by anterior segment optical coherence tomography","volume":"124","author":"Invernizzi","year":"2017","journal-title":"Ophthalmology."},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0146","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.survophthal.2025.11.002","article-title":"Anterior segment optical coherence tomography in uveitis: a comprehensive review of clinical applications, diagnostic insights, and future directions","volume":"71","author":"Feo","year":"2026","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.009_bib0147","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajo.2022.05.012","article-title":"Quantification of anterior chamber cells in children with uveitis using anterior segment optical coherence tomography","volume":"241","author":"Tsui","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0148","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12348-025-00456-y","article-title":"Automated quantification of anterior chamber cells using swept-source anterior segment optical coherence tomography","volume":"15","author":"Pillar","year":"2025","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0149","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.survophthal.2023.10.005","article-title":"Anterior chamber inflammation grading methods: a critical review","volume":"69","author":"Oo","year":"2024","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2026.101106","article-title":"OCT-based evaluation of vitreous haze in the first-line antimetabolites as steroid-sparing treatment uveitis trial","volume":"6","author":"Alhelaly","year":"2026","journal-title":"Ophthalmol Sci"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.009_bib0151","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41433-024-03519-x","article-title":"The history of uveitis: from antiquity to the present day","volume":"39","author":"Ghadiri","year":"2025","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0152","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12969-024-01037-4","article-title":"Reducing the risk of visual disability for children with juvenile idiopathic arthritis uveitis through disease surveillance: past and future challenges","volume":"23","author":"Solebo","year":"2025","journal-title":"Pediatr Rheumatol Online J"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.009_bib0153","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/bjophthalmol-2019-314875","article-title":"Earlier use of systemic immunosuppression is associated with fewer ophthalmic surgeries in paediatric non-infectious uveitis","volume":"104","author":"Cheung","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.009_bib0154","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/09273948.2020.1828493","article-title":"Contemporaneous risk factors for visual acuity in non-infectious uveitis","volume":"29","author":"Pistilli","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","article-title":"Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the systemic immunosuppressive therapy for eye diseases study","volume":"120","author":"Gregory","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2026.08.009_bib0156","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ophtha.2017.12.001","article-title":"The 2016 American Academy of Ophthalmology IRIS\u00ae Registry (Intelligent Research in Sight) database: characteristics and methods","volume":"125","author":"Chiang","year":"2018","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.009_bib0157","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajo.2009.05.033","article-title":"Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye","volume":"148","author":"Galor","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0158","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100112","article-title":"American Academy of Ophthalmology Intelligent Research in Sight (IRIS\u00ae) Registry and the IRIS Registry Analytic Center Consortium","volume":"2","author":"Lee","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ajo.2026.08.009_bib0159","doi-asserted-by":"crossref","DOI":"10.1016\/j.survophthal.2026.06.015","article-title":"Efficacy and safety of different intraocular therapies for non-infectious uveitis: a network meta-analysis","author":"Yang","year":"2026","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.009_bib0160","article-title":"Corticosteroid implants for chronic non-infectious uveitis","volume":"1","author":"Reddy","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.009_bib0161","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12113746","article-title":"Diagnosis, classification, and assessment of the underlying etiology of uveitis by artificial intelligence: a systematic review","volume":"12","author":"Jacquot","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.009_bib0162","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007","article-title":"Immunosuppression for the uveitides","volume":"125","author":"Jabs","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.009_bib0163","article-title":"Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults","volume":"10","author":"Edwards Mayhew","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.009_bib0164","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.009_bib0165","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jama.2019.12618","article-title":"Effect of corticosteroid-sparing treatment with mycophenolate mofetil vs methotrexate on inflammation in patients with uveitis: a randomized clinical trial","volume":"322","author":"Rathinam","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2026.08.009_bib0166","unstructured":"Garrison JA. UpToDate. J Med Libr Assoc. 2003;91(1):97."}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:07:40Z","timestamp":1794301660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426004502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":166,"alternative-id":["S0002939426004502"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.08.009","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LXXXIII Jackson Memorial Lecture: Predicting the Future of Uveitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}